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Acetaminophen (paracetamol), one of the most widely used analgesics, is toxic under conditions
of overdose or in certain disease conditions, but the mechanism of acetaminophen toxicity is
still not entirely understood. To obtain fresh insights into acetaminophen toxicity, this phenomenon
was investigated in yeast. Acetaminophen was found to be toxic to yeast cells, with erg mutants
displaying hypersensitivity. Yeast cells grown in the presence of acetaminophen were found to
accumulate intracellular acetaminophen, but no metabolic products of acetaminophen could be
detected in these extracts. The toxicity response did not lead to an oxidative stress response,
although it did involve Yap1p. The cytochrome P450 enzymes of yeast, Erg5p and Erg11p, did
not appear to participate in this process, unlike the mammalian systems. Furthermore, we could
not establish a central role for glutathione depletion or the cellular glutathione redox status
in acetaminophen toxicity, suggesting differences from mammalian systems in the pathways
causing toxicity. Investigations of the resistance mechanisms revealed that deletion of the
glutathione-conjugate pumps Ycf1p (a target of Yap1p) and Bpt1p, surprisingly, led to
acetaminophen resistance, while overexpression of the multidrug resistance pumps Snq2p and
Flr1p (also targets of Yap1p) led to acetaminophen resistance. The Yap1p-dependent resistance
to acetaminophen required a functional Pdr1p or Pdr3p protein, but not a functional Yrr1p. In
contrast, resistance mediated by Pdr1p/Pdr3p did not require a functional Yap1p, and revealed
a distinct hierarchy in the resistance to acetaminophen.
INTRODUCTION
Acetaminophen (N-acetyl-p-aminophenol, 49-hydroxy-
acetanilide, paracetamol) is one of the most widely used
analgesics and antipyretics. Although it is generally con-
sidered safe at therapeutic doses, in overdose, or in
conjunction with liver disease and other disease conditions,
acetaminophen displays toxicity, leading to morbidity as
well as mortality (Prescott, 1983; Davidson & Eastham,
1966). A great deal of work has gone into investigating
the mechanisms by which acetaminophen is toxic (Howie
et al., 1977; Prescott, 1983; Ray et al., 1993; Ruepp et al.,
2002; Wu et al., 2004) and is detoxified in mammalian
systems. The major pathway for the removal of acetamino-
phen appears to be through glucuronidation and sulpha-
tion, whichmake it more water soluble and allow its removal
from the liver and the blood via the urine (Jollow et al.,
1974). A third metabolic pathway involves the oxidation of
acetaminophen by microsomal cytochrome P450 to NAPQI
(N-acetyl-p-benzoquinone imine), a reactive intermediate.
NAPQI appears to be detoxified via the formation of
glutathione-conjugates followed by their subsequent excre-
tion, since these conjugates and their degradatory products
have been observed in the urine along with a few other
oxidation products.
Despite extensive studies of the mechanisms of acetamino-
phen toxicity, the exact mechanism by which acetamino-
phen is toxic is surprisingly still controversial. Currently,
two major theories have been proposed to explain the
cytotoxicity. Although in both hypotheses the first step is
the generation of the reactive intermediate NAPQI, the
‘glutathione depletion theory’ states that an excess of
NAPQI (generated from acetaminophen by cytochrome
P450) leads to depletion of glutathione, followed by oxida-
tive stress, ultimately leading to cell death. The second
theory, the ‘covalent binding theory’ or the ‘macromol-
ecular inhibition theory’, considers that the major cause
of cell death by acetaminophen is not the result of
glutathione depletion per se, but the result of direct binding
to macromolecules and inhibition of their function by
NAPQI, eventually leading to cell death (Mitchell et al.,
1973; Dahlin et al., 1984; Ruepp et al., 2002).
Abbreviations: MDR, multidrug resistance protein; MRP, multidrug
resistance associated protein; NAPQI, N-acetyl-p-benzoquinone imine;
ROS, reactive oxygen species.
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A second issue complicating studies of acetaminophen
toxicity is the significant differences seen in the susceptibi-
lity of different species and even strains to acetaminophen
toxicity (Potter et al., 1974; Hinson, 1980; Ioannides et al.,
1983). It is not clear whether the increased drug resistance
profiles are due to enhanced/reduced metabolism or other
factors, hitherto unconsidered, such as increased efflux.
Furthermore, the possible role of multidrug resistance
associated proteins (MRPs) in these processes is unclear,
although the involvement of MRPs has been indicated by
one study (Xiong et al., 2000).
The yeast Saccharomyces cerevisiae is an excellent model
system to investigate mechanisms of drug resistance and
toxicity at the cellular level. Not only are most of the
enzymic and cellular structures conserved, but the main-
tenance of the redox balance and oxidative stress response
is also highly conserved, with glutathione being the major
non-protein thiol compound present in yeasts as well as in
higher eukaryotes. In addition, the family of drug resis-
tance pumps found in mammalian cells (the multidrug
resistance proteins, MDRs, and MRPs) are also present as
a family of pumps in yeasts (Decottignies & Goffeau, 1997).
An earlier report investigating the effects of aniline and its
metabolites in yeasts also investigated acetaminophen (an
aniline derivative), and under the conditions in which it
was investigated it was found to be non-toxic (Brennan &
Schiestel, 1997). Considering the potential importance of
yeast in resolving some of the controversial issues relating
to acetaminophen toxicity, such as those described above,
we considered it important to reinvestigate the toxicity of
acetaminophen more rigorously and compare the mechan-
isms of toxicity and resistance with those of mammalian
cells. We decided to investigate this by initially examining
pleiotropically drug-sensitive mutants (certain erg mutants
defective in ergosterol biosynthesis). Acetaminophen was
found to be toxic in these yeast mutants. This allowed one
to examine the possible mechanisms of drug detoxifica-
tion as well as test the existing models concerning the
mechanisms of acetaminophen-induced cell death. The
results suggested that acetaminophen toxicity in yeast is
not due to the generation of reactive oxygen species (ROS)
and is also not dependent on the intracellular glutathione
status. Resistance was conferred by the MRPs Snq2p and
Flr1p and was mediated by Yap1p, Yrr1p and Pdr1p/
Pdr3p. The hierarchy of these factors in the resistance to
acetaminophen was also determined and found to be dis-
tinct from the existing knowledge about their hierarchies.
Together, these findings demonstrate that acetaminophen
can exert its toxicity at the cellular level by pathways
completely different from those considered previously. The
implications of these studies for mammalian cells are also
presented.
METHODS
Chemicals. The chemicals used were of analytical grade. Media
components were purchased from Difco, chemicals from Sigma and
Merck. Acetaminophen (4-acetamidophenol), 2-vinylpyridine and
29,79-dichlorodihydrofluorescein diacetate were obtained from Sigma.
Oligonucleotides were purchased from Biobasics Inc. (Canada).
Restriction enzymes were obtained from New England Biolabs.
Strains, strain construction and growth conditions. The yeast
strains used in this study are listed in Table 1. The cells were
routinely grown in YPD at 30 uC. For selection of transformants and
b-galactosidase assays, minimal medium (SD media) with supple-
ments was used. Acetaminophen stock solutions were prepared in
30% methanol, and the appropriate amounts were added to the
media just prior to pouring the plates. Control plates contained
equivalent amounts of 30% methanol. The strain ABC681 (snq2D)
was constructed by PCR-mediated gene disruption of the SNQ2
gene of ABC154 using the KanMX2 module (Wach et al., 1994).
The disruption cassette was amplified using the primers SNQ2-
DEL1: 59-AAGGTATTAAGGCTAAGAGGCATCAAAAGATGAGAC-
AGCTGAAGCTTCGTA-39 and SNQ2-DEL2: 59-TTTCGAATTC-
CTCAGCGGTTCTTGGTACTTTATTTTCATAGGCCACTAGTGGA-
TC-39. The disruption of the desired locus was confirmed by PCR
using the primers SNQ2-FOR: 59-GATGCGAGTGCCCTAGAA-
GG-39 and SNQ2-REV: 59-CTTGTTCCCAATATGACACT-39. The
pdr15D strain (ABC668) was also constructed by PCR-mediated
gene disruption using the KanMX2 module, using the primers
PDR15-D1: 59-GTCAGAGGTGTTTCTGGTGGTGAAAGAAAGCG-
TGTATCCAGCTGAAGCTTCGTACGC-39 and PDR15-D2: 59-TA-
AGGCAGTCAAAGTGCCTGGTTTTACCCAACCATCTACGTTCAT-
AGGCCACTAGTGGAT-39. Disruptions were confirmed by PCR.
The ABC670 (pdr10D) strain was constructed by first cloning a
1?6 kb BglII–BamHI fragment of PDR10 that was amplified by PCR
into pGEM7Z. A 4?5 kb LYS2 fragment containing the LYS2 gene
was excised by PstI and cloned into the PstI site of PDR10 in
pGEM7Z. A NsiI–ScaI digestion of this pPDR10 : : LYS2 disruption
plasmid was excised and used to transform ABC154. Transformants
were selected on SD media without lysine, and disruptions were
confirmed by PCR.
ABC936, YPH499-GV8-GSH1, a strain which contained an integrated
copy of the GSH1 gene expressed downstream of the GPD promoter,
was constructed by transforming a linearized DNA fragment obtained
by digesting the pGV8-GSH1 plasmid with StuI. pGV8-GSH1 con-
tained the yeast GSH1 gene, which was amplified by PCR and cloned
into theHindIII–BspDI sites downstream of the strong GPD promoter
in a pRS306-derived integrating vector. Transformants were selected
on plates containing SD media without uracil.
The SKN7 gene was disrupted in the ABC949 (wild-type) strain and
ABC950 (yap1D) to yield ABC1041 (skn7D) and ABC1042 (skn7D
yap1D) by transforming a linearized fragment obtained by restriction
digestion of an SKN7 disruption plasmid (skn7D : :TRP1) (Brown
et al., 1993) with SacI. Disruptions were confirmed by PCR and by
t-butylhydroperoxide sensitivity.
Plasmids. PDR5 on a multicopy plasmid (PDR5/Yeplac195) has
been described earlier (Kaur & Bachhawat, 1999); YAP1 on a multi-
copy plasmid and YEp351-YAP1 were obtained from Dr S. Moye-
Rowley; FLR1 on multicopy plasmid p425GPD-FLR1 and the
control plasmid (p425 GPD) from Dr M. Raymond; ATR1 on multi-
copy plasmid Yrp74-Sc4018 and the corresponding control plasmid
(Yrp74) from Dr K. Struhl; YOR1 on multicopy plasmid YEpYRS1
was sent by Dr T. Miyakawa. The plasmid bearing pdr3-9 (hyper-
active allele of Pdr3p) was obtained from Dr J. Subik. The plasmid
bearing GADYRR1* (a gene encoding the hyperactive allele of
Yrr1p) was obtained from Dr C. Jacq.
The pSKN7 plasmid was isolated by library screen in the lab. (Sharma
et al., 2003). pYCF-LacZ and pBPT-LacZ plasmids have been described
previously (Sharma et al., 2002).
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The ERG5 and ERG11 genes were amplified by PCR using vent DNA
polymerase and cloned into the BamHI–XhoI sites of the yeast
expression vector pTEF-416, a single copy centromeric vector. The
primers used for amplification were ERG5-gen-Bam-F (59-ACA AAA
ggA TCC ATgAgT TCT gTC gCA gAA AAT ATA-39) as well as ERG5
gen-Eco-R (59-AAgACTgAATTCTCTCCAgTAATTgggTCTCTC-39)
for ERG5, and ERG11-gen-Bam-F (59-ACA Agg ggA TCC ATg TCT
gCT ACC AAg TCA ATC-39) as well as ERG11-gen-R1-R (59-TTA
CAA gAA TTC ACC TTA gAT CTT TTg TTC Tgg AT-39) for ERG11.
The genes were cloned downstream of the strong and constitutive
TEF promoter and confirmed by sequencing.
Growth experiments. Cells from overnight cultures of strains
ABC154, ABC936 and ABC591 were reinoculated to an OD600 of 0?1
(26106 cells ml21) and allowed to grow to an OD600 of 0?5 to 0?6,
and, at this stage, drug was introduced (16 mg ml21). In control
experiments, an equivalent amount of 30% methanol solution was
added. Growth of these cultures was followed by measuring OD600
values at different time points (at 3 h intervals). At 12 and 24 h
time points, a known number of cells was plated on YPD plates to
check the number of viable cells.
Drug sensitivity experiments. Strains were transformed with
the plasmids, and the transformants were grown in SD media
with appropriate selection until they reached exponential phase, and
then equal numbers of cells were harvested and resuspended in
sterile water to a density of 16107 cells ml21. Portions (10 ml) of
undiluted cell suspension, 1 : 10, 1 : 100 and 1 : 1000 dilutions were
then spotted onto YPD plates containing different concentrations of
acetaminophen. Growth was observed after 2 to 4 days at 30 uC.
Glutathione estimation. The overnight cultures of strains
ABC154, ABC591 (gsh1D) and ABC936 (strain overexpressing GSH1
gene) were reinoculated at OD600=0?1 and acetaminophen was
added when the OD600 reached 0?5–0?6. Glutathione estimation was
carried out using the DTNB-glutathione reductase assay (Anderson
& Meister, 1983) at different time points, as described earlier
(Sharma et al., 2000). Oxidized glutathione levels were measured by
using 2-vinyl pyridine to block the reduced glutathione (Anderson
& Meister, 1983).
Induction conditions and b-galactosidase assays. ABC154 was
transformed with plasmids pYCF-LacZ and pBPT-LacZ, and the
Table 1. List of yeast strains used in the study
Strain Genotype Source
ABC152 (YKKA) Mata ura3-52a leu2-D1 his3-D200lys2-801 PDR5 : :TRP1 K. Kuchler
ABC154 (YPH499) Mata ura3-52 leu2D1 his3-D200 trp-D63 ade2-101 lys2-801 K. Kuchler
ABC229 Mata ura3-52 leu2D1 his3-D200 erg2D : : LEU2 Lab. strain
ABC230 Mata ura3-52 leu2D1 his3-D200 erg4D : : LEU2 Lab. strain
ABC231 Mata ura3-52 leu2D1 his3-D200 erg6D : : LEU2 Lab. strain
ABC470 Mata ura3-52 leu2D1 his3-D200 trp-D63 ade2-101 lys2-801 ycf1D : : KanMX2 Lab. strain
ABC557 Mata ura3-52 leu2D1 lys2-801 his3-D200 erg3D : : LEU2 Lab. strain
ABC582 Mata ura3-52 leu2D1 his3-D200 trp-D63 ade2-101 Lys2-801 gtt1 : :KanMX2 gtt2 : :KanMX2 Lab. strain
ABC583 Mata ura3-52a leu2D1 his3-D200 trp-D63 ade2-101 Lys2-801 gtt2 : :KanMX2 Lab. strain
ABC584 Mata ura3-52 leu2D1 his3-D200 ade2-101lys2-801 Lab. strain
ABC585 Mata ura3-52 leu2D1 his3-D200 ade2-101lys2-801 gtt1D Lab. strain
ABC591 Mata ura3-52 leu2D1 his3-D200 trp-D63 ade2-101 lys2-801 gsh1D : : LEU2 Lab. strain
ABC668 Mata ura3-52 leu2D1 his3-D200 trp-D63 ade2-101 lys2-801pdr5D : :KanMX2 Lab. strain
ABC670 Mata ura3-52 leu2D1 his3-D200 trp-D63 ade2-101 lys2-801pdr10D : : LYS2 Lab. strain
ABC681 Mata ura3-52 leu2D1 his3-D200 trp-D63 ade2-101 lys2-801snq2D : :KanMX2 Lab. strain
ABC709 Mata ura3-52 lys2-801 leu2-D1his3-D200
ABC734 (BY4742) Mata His3D1 leu2D0 lys2D0 ura3D0 Euroscarf
ABC791 Mata ura3-52 leu2D1 his3-D200 trp-D63 ade2-101 lys2-801 bpt1D : :KanMX2 Lab. strain
ABC794 Mata ura3-52 leu2D1 his3-D200 ade2-101 lys2-801bpt1D : :KanMX2 ycf1D : :KanMX2 Lab. strain
ABC936 Mata ura3-52 leu2D1 his3-D200 trp-D63 ade2-101 lys2-801ura3D : :GPD-GSH1-URA3 K. Kuchler
ABC949 (SEY6210) Mata ura3-52 leu2-13 his3-D200 trp1-D901lys2-801 S. Moye-Rowley
ABC950 Mata ura3-52 leu2-13 his3-D200 trp1-D901 lys2-801 Yap1D : :HisG S. Moye-Rowley
ABC1041 Mata ura3-52 leu2-13 his3-D200 trp1-D901 lys2-801 Skn7D : :TRP1 Lab. strain
ABC1042 Mata ura3-52 leu2-13 his3-D200 trp1-D901 lys2-801 Yap1D : :HisG Skn7D : :TRP1 Lab. strain
ABC1114 Mata His3D1 leu2D0 lys2D0 ura3D0 glr1D : :KanMX4 Euroscarf
ABC1139 Mat a trp1 his3 leu2 Ura3 lys2 ade2 gpx 1 : :HIS3 Y. Inoue
ABC1140 Mat a trp1 his3 leu2 Ura3 lys2 ade2 gpx 2 : :URA3 Y. Inoue
ABC1141 Mat a trp1 his3 leu2 Ura3 lys2 ade2 gpx 3 : : LEU2 Y. Inoue
ABC1142 Mat a trp1 his3 leu2 Ura3 lys2 ade2 gpx 1 : :HIS gpx 2 : :URA3 gpx 3 : : LEU23 Y. Inoue
ABC1304 Mata his3D1 leu2D0 lys2D0 ura3D0 yrr1D : :KanMX4 Euroscarf
ABC1374 Mata leu2-3-112 ura3-52 his3-D200 trp1 pdr1D : :HisG S. Moye-Rowley
ABC1374 Mata leu2-3-112 ura3-52 his3-D200 trp1 pdr3D : :HisG S. Moye-Rowley
ABC1376 Mata leu2-3-112 ura3-52 his3-D200 trp1 pdr1D : :HisG Pdr3D : :HisG S. Moye-Rowley
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transformants were assayed for b-galactosidase in the presence or
absence of acetaminophen (14 mg ml21). b-Galactosidase assays
were carried out on permeabilized cells, as previously described
(Guarente, 1983; Sharma et al., 2002).
Detection of intracellular acetaminophen. Cells of strain
ABC154 were inoculated in YPD media and allowed to grow over-
night, reinoculated at OD600=0?2 and allowed to grow for 3–4 h.
To this growing culture, acetaminophen was added at 8 mg ml21,
and the incubation continued for 4–6 h. The cells from this culture
were harvested, washed thoroughly (twice) with sterile distilled
water, and lysed using 5% sulfosalicyclic acid and glass beads. The
lysate was centrifuged at 5000 r.p.m. for 5 min to settle the unbroken
cells and the cell debris. The supernatant was mixed with two
volumes of ethyl acetate and vortexed vigorously for 1 min, the
mixture was allowed to settle and the ethyl acetate layer was
separated. The aqueous and ethyl acetate extract fractions were
lyophilized, and the residues redissolved in small amounts of water
and ethyl acetate, respectively. An aliquot of each of the ethyl acetate
and aqueous extracts was subjected to mass spectroscopy (100–600
a.m.u.) through direct infusion under positive atmospheric pressure
chemical ionization (APCI). A separate aliquot of the ethyl acetate
fraction was used for LC-MS experiments (100–600 a.m.u., positive
APCI) using a PDA detector.
Fluorescence assays using 2§,7§-dichorodihydrofluorescein
diacetate. Overnight cultures of ABC154 (wild-type strain) and
ABC681 (snq2D strain) were each subcultured into eight different
flasks with 5 ml fresh medium at a concentration of 0?56107 cells
ml21 and incubated at 30 uC at 200 r.p.m. for 2 h. The test chemi-
cals H2O2 and acetaminophen (at final concentrations of 4 mg ml
21
and 18 mg ml21, respectively) were added to two flasks each of the
wild-type and snq2D strain. The cultures were incubated for about
1 h and then 29,79-dichlorodihydrofluorescein diacetate (DCFHDA)
was added from a fresh 5 mM stock (prepared in ethanol) to a final
concentration of 10 mM and the incubation was continued for a
further 2 h. This permitted deacetylation of the dye and rendered it
susceptible to oxidation in the presence of any ROS. About 1?5 ml
of sample was removed from each of the above cultures and cells
were harvested by centrifugation, washed twice with sterile water
and resuspended in 100 ml 50 mM Tris/HCl buffer (pH 7?5). The
cells were permeabilized by adding 50 ml chloroform and 20 ml
0?1% SDS and by vortexing at high speed for 20 s. The tubes were
left to stand for 10 min to allow the dye to diffuse into the buffer.
Cells were pelleted in a microcentrifuge, and the fluorescence of the
supernatant was measured using a Shimadzu fluorimeter (excitation,
502; emission, 521).
RESULTS
Yeast strains undergo acetaminophen-induced
cell death in the presence of acetaminophen,
with erg strains displaying hypersensitivity to
acetaminophen
Although an earlier report had indicated a lack of acet-
aminophen toxicity in yeast (Brennan & Schiestel, 1997), we
decided to re-examine the issue by initially using erg
mutants, which display an increased sensitivity to a wide
variety of drugs. Earlier studies have shown that mutants
in the ergosterol biosynthetic pathway, particularly those
disrupted in the latter half of the pathway, display an
increased drug sensitivity which arises both from an
increased influx of the drugs through the membranes,
which are more permeable, and from decreased efflux by
membrane pumps, which function less efficiently in an
altered membrane environment (Kaur & Bachhawat, 1999).
As seen in Fig. 1, the erg2D and erg6D mutants in fact
displayed a significant acetaminophen sensitivity. The erg3D
and erg4D mutants showed slightly less sensitivity than the
erg2D and erg6Dmutants, but they also showed an increased
sensitivity to the drug compared to the wild-type strains.
These observations prompted us to examine the issue of
acetaminophen toxicity further and to examine the nature
of the inhibition of growth by acetaminophen. Examination
of different wild-type strains of S. cerevisiae in different
genetic backgrounds revealed that wild-type strains were
also sensitive to acetaminophen, although at increased
concentrations, but the sensitivities differed in different
backgrounds. We subsequently focused on the wild-type
YPH499 (S288C background). We determined whether
the growth inhibition observed in these strains was a
consequence of growth stasis or of cell death. Cells were
grown in YPD medium and acetaminophen was added to
exponentially growing cells. At 24 h intervals, aliquots
were plated to check for cell viability. After 72 h of growth
in the presence of acetaminophen, there was a significant
drop in cell viability, and the cells failed to recover even
after removal of drug (data not shown). This was similar to
the cell death observed in mammalian cells, and it further
WT
 
 
 
YPD control 
4 mg ml
_1 14 mg ml
_1
erg2D erg3D
erg4Derg6D
Fig. 1. erg strains are hypersensitive to acetaminophen. The
strains erg6D (ABC231), erg3D (ABC557), erg4D (ABC230),
erg2D (ABC229) and the corresponding wild-type strain
(ABC709) were streaked on YPD plates containing 4 and
14 mg acetaminophen ml”1 and incubated at 30 6C. The YPD
control plate contains an equivalent amount of 30% methanol
solution (Methods). WT, Wild-type.
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suggested that we could use yeasts to examine the mechan-
ism of acetaminophen-induced cell death.
Identification of intracellular acetaminophen
(but no other metabolites of acetaminophen) in
yeast cells grown in the presence of the drug
To determine if the acetaminophen-induced cell death
was a result of acetaminophen or some other metabolite
accumulating intracellularly, it was necessary to establish
the accumulation of acetaminophen (or its metabolites)
within the cell.
Whole-cell lysates of cells grown in the presence of acet-
aminophen were extracted with ethyl acetate (Methods)
and the ethyl acetate and aqueous fractions were subjected
to direct infusion mass spectroscopy. In each occasion, the
peak at m/z 152 in the respective mass chromatogram
indicated the presence of acetaminophen. However, the
mass chromatogram did not reveal any new peaks of
significant intensity. In order to investigate the accumula-
tion of the drug inside the cell and to examine the possibility
of any new peaks we further carried out LC-MS studies of
the ethyl acetate fraction using a PDA detector. A major
component with a retention time comparable to that of
standard acetaminophen exhibited a peak at m/z 152 in the
MS, revealing the presence of the drug in the ethyl acetate
extract. The LC-MS did not reveal the presence of any new
peak relative to the control, suggesting that the principal
compound accumulating in these cells was acetaminophen
and that no other transformed products of this drug were
being generated. However, the possibility that other
metabolic products (such as NAPQI) were being formed
and rapidly removed from the cell, or conjugated to proteins
preventing their extraction, still existed.
Overexpression of yeast-cytochrome-P450-
encoding Erg5p (C22 sterol desaturase) and
Erg11p (lanosterol demethylase) does not alter
the acetaminophen resistance profiles in yeast
The inability to detect any other metabolites of acetamino-
phen suggested that acetaminophen was exerting its toxicity
independently of a biotransformation step. This was in
apparent contrast to mammalian cells, in which the acti-
vation of acetaminophen to the reactive intermediate has
been shown to be dependent on the presence of specific
cytochrome p450 enzymes. NAPQI is a very short-lived
intermediate and, in the studies with mammalian cells,
only 1% of the acetaminophen is converted into NAPQI
through cytochrome P450. The possible involvement of the
yeast cytochrome P450s in toxicity needed more thorough
investigation. S. cerevisiae has three P450 enzymes which
play important metabolic roles in the cell. Erg5p (Skaggs
et al., 1996) and Erg11p (Aoyama et al., 1981) are involved
in ergosterol biosynthesis, and homologues of these pro-
teins are widely distributed in other yeasts as well. The third
protein, Dit2p, is involved in the spore wall formation of
S. cerevisiae, and is unique to S. cerevisiae (Briza et al., 1990).
Among these different P450 enzymes in yeast, only Erg5p
has been implicated in also contributing to the detoxifica-
tion pathway of some metabolites. To examine the possible
role of Erg5p and Erg11p in the toxicity of (or resistance to)
acetaminophen, we cloned and overexpressed these genes
from a strong constitutive promoter. Both Erg5p and
Erg11p overexpression could confer increased resistance to
fluconazole, but we could not find any increased sensitivity
or resistance to acetaminophen upon either Erg5p or Erg11p
overexpression (data not shown).
Acetaminophen toxicity in yeast: absence of a
role for glutathione
The inability to detect any intracellular metabolites other
than acetaminophen in acetaminophen-treated cells and
the lack of involvement of the yeast cytochrome P450s
strongly suggested a toxicity mechanism that differed from
the primary mechanism of toxicity observed in mammalian
cells, in which reactive metabolites are generated through
the action of specific cytochrome P450s. We decided to
examine more rigorously whether the yeast cells were in
fact subjected to an oxidative stress response in the pres-
ence of acetaminophen, and also if the glutathione status
of the cell was important in the cellular response to
acetaminophen.
We decided to initially examine this using 29,79-dichloro-
dihydrofluorescein diacetate, a fluorogenic compound
which has been used by several workers as a marker for
oxidative stress and which is suggested to reflect the over-
all oxidative stress status of the cells, although its use as
a marker of overall oxidative status is still controversial.
Experiments were carried out as described in Methods.
Cells exposed to H2O2 displayed a significant increase
in fluorescence intensity, but no increase in fluorescence
intensity was observed when cells were treated with
acetaminophen concentrations from 4 to 18 mg ml21 for
a period of 1 to 2 h (Fig. 2). This confirmed that the cells
were not being subjected to oxidative stress. However, the
limitations of the assay in being responsive to, and there-
fore suitable for, only some oxidants (Myhre et al., 2003;
Chignell & Sik, 2003) prompted us to investigate more
carefully the role of glutathione, since glutathione deple-
tion has been implicated in the acetaminophen toxicity of
mammalian cells.
To examine if glutathione depletion played a crucial role
in acetaminophen toxicity in yeast we constructed strains
that had either depleted or elevated levels of glutathione.
The strains with depleted levels were the result of the
deletion of GSH1, the gene for the first enzyme in gluta-
thione biosynthesis. These cells take up glutathione from
the external medium through specific glutathione trans-
porters (Bourbouloux et al., 2000), but the levels of
intracellular glutathione rarely reach beyond 50% of
the wild-type levels of glutathione (Sharma et al., 2000).
The strains overproducing glutathione were constructed
by integrating a copy of GSH1 that we had expressed
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downstream of the strong constitutive TEF promoter. The
levels of GSH in these latter strains in YPD medium were
threefold higher than wild-type levels (data not shown).
We grew these cells in YPD medium, and at an OD600 of
about 0?5 to 0?6 we added acetaminophen to the cells and
followed further growth. At 3 h intervals, we took aliquots
to monitor the growth and in addition to monitor the
glutathione levels of the different cells. In contrast to what
we expected, irrespective of the intracellular glutathione
content of the cells, there was no difference in the growth
inhibition induced by acetaminophen. Furthermore, drug-
treated cells did not show any significant decrease in
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Fig. 2. Acetaminophen response detected by 29,79-dichlorodihydrofluorescein diacetate assay. Fluorescence of the cell
extracts from strains ABC154 (wild-type) and ABC681 (snq2D) following 1 h exposure to H2O2 (bars 2 and 6) or different
concentrations of acetaminophen (4 mg ml”1, bars 3 and 7; 18 mg ml”1, bars 4 and 8) in the presence of 29,79-
dichlorodihydrofluorescein diacetate. The bars represent the fluorescence intensity observed at 521 nm in arbitrary units
(A.U.). Each experiment was done at least in duplicate (details in Methods). WT, Wild-type.
Fig. 3. Effect of glutathione depletion on
acetaminophen toxicity. (a) The strains
ABC154 (wild-type) and ABC591 (gsh1D),
were grown in YPD for 10 to 12 h and re-
inoculated to OD600=0?1. These cultures
were allowed to grow to OD600=0?5–0?6
and then acetaminophen was added at
16 mg ml”1. m and &, ABC154 strain; x
and $, gsh1D strain. (b) Effect of acetamino-
phen treatment on intracellular GSH levels.
Intracellular GSH estimation was carried out
as described in Methods. Bars represent
intracellular GSH levels (nmol) of wild-type
(white bars) and gsh1D cells (black bars).
The various time points of the determination
are indicated on the tops of the bars. +,
Drug-treated samples; ”, control samples
without drug. The figure is representative of
three independent experiments. WT, Wild-type.
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glutathione levels compared to untreated cells (Fig. 3),
providing further evidence against depletion of glutathione
levels as the primary cause of the toxicity of the drug.
To examine if the glutathione redox status of the yeast
cells might be important, we further examined the res-
ponse of yeast cells disrupted for glutathione reductase
(glr1D) to acetaminophen. Although the absence of gluta-
thione reductase is not lethal for S. cerevisiae, such cells
are much more sensitive to the presence of drugs that
generate an oxidative stress response, owing to the elevated
GSSG/GSH ratio (Grant et al., 1996). However, the glr1D
cells failed to show an enhanced sensitivity to acetamino-
phen. Furthermore, acetaminophen-treated cells also failed
to show an alteration in GSSG/GSH ratio compared to
untreated cells (data not shown), clearly underlining firstly
the fact that acetaminophen was not inducing an oxidative
stress response in yeast, unlike the response observed in
mammalian cells, and secondly that neither glutathione
depletion nor the glutathione redox status was involved in
the toxicity of acetaminophen.
Yeast cell response to acetaminophen: role of
Yap1p in resistance to acetaminophen
Yap1p is a transcription factor known to play a central
role in the oxidative stress response of yeast (Moye-Rowley
et al., 1988) as well as in the response to several drugs that
generate an oxidative stress response.
Acetaminophen toxicity was initially examined in strains
deleted for YAP1. Our results clearly indicated that yap1D
strains displayed an increased sensitivity to acetaminophen
(Fig. 4a). Furthermore, overexpression of Yap1p in wild-
type cells conferred increased resistance to acetaminophen
(Fig. 4b), confirming the role of Yap1p in the response to
cellular injury by acetaminophen. We also investigated if
Skn7p, a second transcription factor also implicated in the
cellular oxidative stress response (Morgan et al., 1997),
might also be involved in the response to acetaminophen.
However, neither the deletion of SKN7 nor the over-
expression of SKN7 from a multicopy plasmid led to any
discernable phenotype in the presence of acetaminophen
(Fig. 4a, b). A deletion of SKN7 in a yap1D background
was also constructed to see if the phenotypes of an skn7D
deletion might be seen in this background. However, no
further increase in acetaminophen sensitivity was observed
in the skn7D yap1D strains compared to yap1D strains.
This indicated that, of the two oxidative-stress-responsive
transcription factors, only Yap1p played a role in the
response to acetaminophen. Although it has been widely
used as an indicator of oxidative stress response in yeasts,
recent studies have indicated that there are two independent
mechanisms of Yap1p activation, one dependent on oxida-
tive free radicals, and another which acts at an independent
site of Yap1p which is activated by electrophiles (Azevedo
et al., 2003). The lack of ROS suggested that the acetamino-
phen response of Yap1p was occurring through the latter
mechanism. To further confirm this, we examined the
effects of gpx3D (orp1D) on acetaminophen sensitivity.
The oxidative response of Yap1p has been shown to be
dependent on the presence of Gpx3p (Delaunay et al., 2002).
We could not observe any effect of the presence of Gpx3p
on the sensitivity to acetaminophen, further underlining
that Yap1p was not functioning through this pathway and
that it was being activated through an electrophilic com-
pound which was not dependent on an oxidative stress
response.
Disruption of the yeast glutathione-conjugate
pumps Ycf1p and Bpt1p leads to
acetaminophen resistance
The Yap1p transcriptional activator is known to activate a
very large number of genes. Among these is a gene directly
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Fig. 4. The oxidative-stress-responsive transcription factor
Yap1p, but not Skn7p, plays a role in acetaminophen resis-
tance. (a) The deletion strains skn7D (ABC1041), yap1D
(ABC950), skn7D yap1D (ABC1042) along with the corre-
sponding wild-type (WT) strain (ABC949) were streaked on
YPD plates with or without 14 mg acetaminophen ml”1. Plates
were incubated for 2 to 4 days at 30 6C and scored for
growth. (b) Multicopy plasmids bearing SKN7 or YAP1, and
control vectors, were transformed into ABC154. Transformants
were picked up and grown in SD media; uracil and spotting
experiments were performed as indicated in Methods.
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implicated in the glutathione detoxification pathways, the
yeast glutathione-conjugate pump Ycf1p.
Overexpression of Yap1p leads to a greater than 10-fold
induction of YCF1 (Wemmie et al., 1994). We therefore
decided to examine the role played by the yeast glutathione-
conjugate pumps Ycf1p and Bpt1p. Bpt1p is a close
homologue of Ycf1p, which has recently been also shown
to function as a glutathione-conjugate pump but is not
regulated by Yap1p (Sharma et al., 2002; Klein et al., 2002;
Chaudhuri et al., 1997). These pumps have also been
shown to transport unconjugated compounds (Pascolo
et al., 2001; Petrovic et al., 2000). However, in contrast
to what we expected, we observed that deletion of both
YCF1 and BPT1 led to an increase in resistance to acet-
aminophen (Fig. 5). This resistance to acetaminophen was
observed in a very narrow range of drug concentrations.
The results were unexpected and were also in apparent
conflict with the fact that Ycf1p is upregulated by Yap1p,
as well as the observation, described above, that Yap1p
leads to increased resistance to acetaminophen. To examine
how acetaminophen affected the induction of YCF1 and
BPT1, we checked the expression pattern of YCF1 and BPT1
using promoter–LacZ fusions in the presence of acetami-
nophen. Only YCF1 (and not BPT1 or the other members
of the group) is known to be induced by Yap1p (Wemmie
et al., 1994; Sharma et al., 2002, 2003). However, in the
presence of acetaminophen we observed only a negligible
(1?5-fold) increase in b-galactosidase activity in both YCF1
and BPT1 (Table 2). These results indicate that, although
Yap1p does play a role in resistance to acetaminophen, the
response of YCF1 (a target of Yap1p) might be influenced
by other unknown regulatory factors in addition to Yap1p.
Furthermore, it suggests that the H2O2-activated Yap1p
and the thiol-compound-activated Yap1p show differential
activation responses. The increased resistance of ycf1D bpt1D
strains to acetaminophen, though small, possibly suggests
some involvement of Ycf1p and Bpt1p in the process,
although the exact manner in which this might be occurr-
ing is not clear. We also overexpressed the YCF1 gene from a
multicopy plasmid, but no phenotypes on acetaminophen-
containing plates could be discerned upon overexpression of
YCF1 (data not shown).
Role of the multidrug resistance pumps in
acetaminophen resistance
Although yap1D strains did possess an increased sensitivity
to acetaminophen and Yap1p overexpression led to an
increase in acetaminophen resistance, it did not appear that
Yap1p-mediated resistance was dependent on the enzymes
related to glutathione-mediated detoxification pathways.
We therefore sought to examine if Yap1p might be acting
through a completely different set of targets. Yap1p is also
known to act on Snq2p, an ABC transporter involved in
multidrug resistance (Sevos et al., 1993), as well as on other
MRPs (DeRisi et al., 1997). Although work with mam-
malian cells has not implicated MRPs in acetaminophen
resistance/sensitivity, we decided to examine the involve-
ment of such proteins in yeast. We examined different
strains deleted in the different ABC transporters to see if
they might be involved in mediating drug resistance to
acetaminophen. Pdr5p as well as Snq2p have been shown
to mediate drug resistance to a number of different
compounds (Balzi et al., 1994; Balzi & Goffeau, 1995;
Decottignies et al., 1995; Decottignies & Goffeau, 1997).
Close homologues of Pdr5p are Pdr10p and Pdr15p, but
these proteins have not been demonstrated to confer
resistance to drugs effluxed by Pdr5p. We nevertheless
examined strains deleted in pdr5, pdr10, pdr15 as well as
snq2 for their acetaminophen sensitivity. Only snq2D
strains displayed a dramatic increase in acetaminophen
sensitivity (Fig. 6a). This was further confirmed by Snq2p
overexpression (Fig. 6b). We also examined the phenotypes
of Pdr5p overexpression, as well as the overexpression of
another ABC transporter, Yor1p, which belonged to the
family of the YCF1 cluster of proteins. However, neither
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Fig. 5. Deletion of the GSH-conjugate pumps Ycf1p and
Bpt1p leads to acetaminophen resistance. ycf1D (ABC470),
bpt1D (ABC791), ycf1D bpt1D (ABC794) and the corres-
ponding wild-type (WT) strains (ABC154) were spotted on YPD
pates with or without 12 mg acetaminophen ml”1.
Table 2. Induction of YCF1 and BPT1 in response to acet-
aminophen
b-Galactosidase reporter-gene assays were performed after
induction (6 h) in medium containing 5 and 10 mg acetamino-
phen ml21, as described in Methods. Results shown are in
b-galactosidase units, and are the mean of three independent
transformants±1SD.
Plasmid Acetaminophen concentration
in medium (mg ml”1):
0 5 10
pYCF1-lacZ 2?69±0?12 4?05±0?21 4?43±0?17
pBPT1-lacZ 2?55±0?12 3?72±0?18 3?97±0?04
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Pdr5p overexpression nor Yor1p overexpression conferred
any resistance to acetaminophen.
Although Snq2p clearly appeared to be the major pump
involved in resistance to acetaminophen, it was of interest
to examine if other pumps might also be involved. This
was also prompted by our observation that when Yap1p
was overexpressed in snq2D strains we still observed a small
increase in drug resistance, even in this (snq2D) back-
ground (Fig. 7). This indicated that additional targets of
Yap1p might be involved in efflux of the drug. In earlier
studies, including a genome-wide analysis of genes induced
by Yap1p, two other multidrug resistance pumps were
observed to be targets of Yap1p (Alarco et al., 1997; DeRisi
et al., 1997). These were Flr1p (Bro´co et al., 1999) and Atr1p,
an aminotriazole resistance protein (Kanazawa et al., 1988).
We therefore sought to examine if these pumps might also
contribute to resistance to acetaminophen. These genes
were transformed into wild-type yeast strains on multicopy
plasmids and the transformants checked for resistance to
acetaminophen. Flr1p clearly contributed to acetamino-
phen resistance (Fig. 8), although Atr1p did not seem to
play any role in acetaminophen resistance (data not shown).
It thus appeared that Yap1p was possibly mediating its
effects on acetaminophen resistance through the multidrug
resistance pumps Snq2p and Flr1p.
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Fig. 8. FLR1 overproduction confers resistance to acetamino-
phen. ABC154 strain and snq2D (ABC681) were transformed
with plasmids bearing the FLR1 gene (p425GPD-FLR1) and
an empty plasmid (p425GPD). The transformants were spotted
on acetaminophen (10 and 16 mg ml”1) and control YPD
plates as indicated in Methods.
Fig. 7. YAP1 overexpression confers resis-
tance to acetaminophen in an snq2D back-
ground. The strain snq2D (ABC681) was
transformed with plasmid YEp351-YAP1 (a
multicopy plasmid harbouring the YAP1
gene). The transformants were grown in SD
media lacking uracil and spotting was per-
formed on YPD and YPD plus acetamino-
phen (10 mg ml”1) plates as indicated in
Methods.
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Fig. 6. The multidrug resistance pump Snq2p plays a role in
acetaminophen resistance. (a) Wild-type strain ABC154 (WT)
and deletion mutants for the MDR pumps snq2D (ABC681),
pdr5D (ABC152), pdr15D (ABC668) and pdr10D (ABC670)
were streaked on YPD control plates and YPD plates with
acetaminophen (4 mg ml”1, as indicated above). (b) ABC154
strain was transformed with control plasmid pRS426, and multi-
copy plasmids bearing either YOR1 (Yep-YRS1), SNQ2 or
PDR5 (PDR5/Yeplac195). The transformants were grown to
exponential phase in SD media lacking uracil at 30 6C and
spotted on YPD or YPD plus acetaminophen (18 mg ml”1)
plates (Methods).
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The Yap1p response to acetaminophen is
dependent on the presence of a functional
Pdr1p or Pdr3p protein
Pdr1p and Pdr3p are among the primary regulators of
pleiotropic drug resistance in yeast (Mamnun et al., 2002),
and their targets include the multidrug efflux protein
Snq2p, which is primarily responsible for acetaminophen
resistance in yeast. A second transcription factor that has
also been involved is Yrr1p. We therefore investigated if
the Yap1p-mediated resistance to acetaminophen might
be mediated through Pdr1p, Pdr3p or Yrr1p, or was func-
tioning independently of these proteins. We observed that,
while the pdr1D and yrr1D strains showed an increased
sensitivity to acetaminophen, pdr3D strains displayed no
increase in sensitivity. To determine if the Yap1p response
was dependent on the presence of either of these proteins,
we overexpressed Yap1p in wild-type strains as well as in
the pdr1D, pdr3D and pdr1D pdr3D strains, and in yrr1D
strains. Interestingly, while Yap1p overexpression con-
tinued to confer resistance to acetaminophen in a pdr1D as
well as in a yrr1D background (Fig. 9), it failed to do so in
a pdr1D pdr3D background. Yap1p-mediated resistance to
acetaminophen was therefore dependent on the presence
of either Pdr1p or Pdr3p, despite the fact that the absence of
Pdr3p did not affect the acetaminophen resistance profile.
To determine if the activity of Pdr1p/Pdr3p or Yrr1p
might be dependent on a functional Yap1p we expressed
hyperactive alleles of Pdr3p (encoded by pdr3–9) (Kozovska
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Fig. 9. Yap1p-mediated resistance to acetaminophen requires Pdr1p or Pdr3p, while the resistance caused by Pdr3-9p is
independent of Yap1p. (a) Yeast strains ABC949 (WT), ABC1374 (pdr1D), ABC1375 (pdr3D) and ABC1376 (pdr1D pdr3D)
were transformed with plasmids overexpressing YAP1 and the corresponding empty vector. The transformants were picked
and grown in the same selection media and then spotted on to YPD plates bearing different concentrations of acetaminophen,
as described in Methods. (b) ABC949 (WT) and ABC950 (yap1D) were transformed with plasmids overexpressing YRR1,
pdr3-9 and p416. The transformants were grown in minimal media and spotted on YPD plates containing different
concentrations of acetaminophen. (c) ABC1376 (pdr1D pdr3D) and ABC1304 (yrr1D) strains were transformed with
plasmids overexpressing YRM1, pdr3-9 and p416 (empty vector). The transformants were picked and grown in the same
selection media and then spotted on to YPD plates bearing different concentrations of acetaminophen, as described in
Methods.
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et al., 2001) and Yrr1p (encoded by GAD–YRR1*) (Le Crom
et al., 2002) in yap1D as well as yrr1D and pdr1D pdr3D
backgrounds. We observed that pdr3–9 could confer resis-
tance in a yap1D as well as a yrr1D background (Fig. 9). In
contrast, GAD-YRR1 overexpression, while restoring resis-
tance to the increased sensitivity of yrr1D strains, could
not confer any resistance in either a yap1D or a pdr1D
pdr3D background. In the case of acetaminophen resistance,
therefore, the resistance is determined by a hierarchy of
transcription factors, and appears to be distinct from the
existing patterns of hierarchy for other reported drugs and
targets.
DISCUSSION
In the present paper, we have examined acetaminophen
toxicity in yeasts to see if it can shed light on themechanisms
of acetaminophen toxicity observed in mammalian cells.
Considering the extensive use of this over-the-counter drug
worldwide, any information on the mode of toxicity would
be of crucial value in the judicious administration of this
drug, especially in the presence of certain disease conditions
(Prescott, 1983; Herzenberg et al., 1997).
The study clearly demonstrated the toxicity of acetamino-
phen in yeasts, although it became apparent only at higher
concentrations of the drug or in ergosterol biosynthetic
mutants.
Unlike mammalian cells, however, acetaminophen failed to
induce an oxidative stress response in yeasts. The studies
clearly show the involvement of Yap1p in acetaminophen
resistance. However, Yap1p can be activated either by ROS
or by electrophiles (Azevedo et al., 2003), and in the case
of acetaminophen it appears that it is the generation of
electrophiles, but not ROS, that is activating Yap1p.
Acetaminophen itself is not considered an electrophile,
while NAPQI, a metabolic product of acetaminophen, is
an electrophile. The inability to detect any metabolites of
acetaminophen probably explains the relative lack of toxi-
city of this compound in yeast. Since the toxicity was also
not enhanced by increasing the levels of the two cytochrome
P450s (Erg5p and Erg11p), there are two possible explana-
tions for the toxicity of acetaminophen in yeast:
(i) acetaminophen itself (independent of its activation to
NAPQI) can act as a weak electrophile;
(ii) the activation of acetaminophen occurs at exceedingly
low levels in yeast, by a mechanism independent of the
cytochrome P450s.
Both possibilities are intriguing, since they have not been
considered in mammalian cells, and in the light of the
results described here, these possibilities need to be seriously
examined in mammalian cells too.
The experiments designed to evaluate the role of gluta-
thione depletion or glutathione redox status on acetami-
nophen toxicity clearly argue against a role for glutathione
depletion per se being the causative agent in acetaminophen
toxicity.
Deletion of the genes for the glutathione conjugate pumps
YCF1 and BPT1 surprisingly led to resistance to acetami-
nophen. This was an unexpected observation, since Ycf1p
levels are actually enhanced by Yap1p. While a possible
explanation is that the GSH conjugates in this case are
more toxic, as has been suggested for some drugs (Monks
& Lau, 1998), an alternative explanation is that accumula-
tion of toxic intermediates and other cellular metabolic
intermediates in a ycf1D bpt1D deletion strain may be
causing a feedback inhibition of the enzymes responsible for
the production of the toxic intermediate.
One of the surprising observations that was made in this
study is that acetaminophen could be effluxed by the yeast
multidrug resistance pump Snq2p (and to a lesser extent
by Flr1p). In addition to the relative lack of formation of
reactive acetaminophen metabolites (such as NAPQI), the
efflux of acetaminophen by multidrug resistance trans-
porters might be a second reason for the relative lack of
toxicity of these drugs to wild-type yeasts and the con-
sequent toxicity of the drug only at elevated concentrations.
Furthermore, the findings would suggest that one should
examine the role of these pumps in mammalian cells more
carefully. Although the relative difference in tissue and
species specificity of the effects of acetaminophen have
been attributed to differences in the metabolism of the drug,
the possibility that differences in direct drug efflux are a
cause also needs to be examined more carefully.
Interestingly, in addition to YAP1, deletions in YRR1 and
PDR1 led to an increased sensitivity to acetaminophen,
indicating the involvement of the drug-resistance regulatory
network in acetaminophen resistance. While the Yap1p
response required a functional Pdr1p or Pdr3p protein,
the resistance conferred by Pdr1p/Pdr3p as seen through a
hyperactive pdr3–9 allele could occur independently of
either Yap1p or Yrr1p, suggesting a hierarchy of these
transcription factors in the resistance to acetaminophen. A
link between Yap1p and Pdr1p/Pdr3p has previously been
shown for diazaborine resistance (Wendler et al., 1997;
Jungwirth et al., 2000) and for benomyl resistance (Tenreiro
et al., 2001). In the case of diazaborine resistance it was
observed that the resistance due to Yap1p was dependent
on a functional Pdr1p or Pdr3p protein, but in this case
the pumps conferring resistance were Ycf1p and Flr1p.
More recently, it has been shown that the pdr3–33 muta-
tion (a gain of function allele of PDR3) could specifically
mediate resistance to diazaborine through Snq2p and
Pdr5p, while a pdr1–12 mutant (a gain of function of
PDR1) mediated resistance to the same drug through Ycf1p
and Flr1p (Wehrschutz-Sigl et al., 2004). In the case of
benomyl resistance, Flr1p appeared to be the primary
pump involved in resistance, and was dependent on Yap1p
and partially on a functional Pdr1p or Pdr3p (Tenreiro
et al., 2001). Our investigations, while describing a quite
different hierarchy in the resistance to acetaminophen, has
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also opened up several other interesting issues and con-
siderations on the toxicity of acetaminophen in relation to
the pathways and networks that mediate resistance.
In conclusion, our studies investigating acetaminophen
toxicity in yeast have demonstrated that acetaminophen
can exert its toxicity in these unicellular eukaryotes by
mechanisms quite distinct from those otherwise observed
and described in mammalian systems. The possibility that
toxic effects of acetaminophen through these pathways
might also be operating (at a secondary level, perhaps) in
mammalian cells thus needs to be examined, especially so
in the light of the drug’s wide usage. The studies described
here also throw light on important aspects of the resis-
tance to the drug in yeast which might also help in resolv-
ing some of the conflicting issues regarding the toxicity in
humans of this widely used drug.
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